- Successfully recruited and assembled a team of seasoned sales and marketing executives and technical salesmen with relevant pulp & paper industry experience in promoting and maintaining sales relationships involving substantial ongoing sales and technical servicing. The new team includes a Vice President of Sales & Marketing
- Enzymes, a Vice President - Pulp & Paper Division, and 5 technical sales representatives. The team's composition reflects the company's understanding of the company's products exceptional value proposition to the pulp & paper industry as well as the understanding of complexities of the sales process into this industry, where its customer decision makers are responsible for the physical plants costing, in many instances, several hundred million dollars or more, and are accustomed to dealing with highly technical sales teams with strong support competencies, following long-term trials of new products.
- Continued the development of the C1 Host Technology for the production of a wider variety of proteins from diverse s their ces, potentially including human therapeutic proteins. Using gene knock-out technology, the company successfully eliminated several genes suspected of limiting expression of foreign proteins in C1 and is in the process of testing the effect of these knock-outs on the expression levels.
Through the removal of unwanted or interfering genes, their gene knock-out technology has shown some promise of producing human proteins at higher yields. Although the initial results are not at the levels they ultimately desire, the results of expression experiments in the improved strains suggest higher stability of the expressed proteins.
marketing@alchempro.com
